Don Rockey to Hepatic Encephalopathy
This is a "connection" page, showing publications Don Rockey has written about Hepatic Encephalopathy.
Connection Strength
5.915
-
Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis: 2 Randomized, Placebo-controlled Trials. Clin Gastroenterol Hepatol. 2023 03; 21(3):723-731.e9.
Score: 0.801
-
Ammonia Levels Do Not Guide Clinical Management of Patients With Hepatic Encephalopathy Caused by Cirrhosis. Am J Gastroenterol. 2020 05; 115(5):723-728.
Score: 0.691
-
Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia. Semin Liver Dis. 2016 Feb; 36(1):48-55.
Score: 0.516
-
Novel Ammonia-Lowering Agents for Hepatic Encephalopathy. Clin Liver Dis. 2015 Aug; 19(3):539-49.
Score: 0.491
-
Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy-Reply. JAMA Intern Med. 2015 May; 175(5):868-9.
Score: 0.488
-
Lactulose vs polyethylene glycol 3350--electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial. JAMA Intern Med. 2014 Nov; 174(11):1727-33.
Score: 0.472
-
Hepatic encephalopathy: how to test and treat. Curr Opin Gastroenterol. 2014 May; 30(3):265-71.
Score: 0.456
-
Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy. Hepatology. 2014 Mar; 59(3):1073-83.
Score: 0.451
-
Altered mental status in cirrhosis: etiologies and outcomes. J Investig Med. 2013 Apr; 61(4):695-700.
Score: 0.423
-
Variability and Lability of Ammonia Levels in Healthy Volunteers and Patients With Cirrhosis: Implications for Trial Design and Clinical Practice. Am J Gastroenterol. 2020 05; 115(5):783-785.
Score: 0.173
-
Editorial: Advances in Hepatology: 2019. Curr Opin Gastroenterol. 2019 05; 35(3):135-136.
Score: 0.161
-
Overuse of Head Computed Tomography in Cirrhosis With Altered Mental Status. Am J Med Sci. 2016 05; 351(5):459-66.
Score: 0.129
-
Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy. Dig Dis Sci. 2016 06; 61(6):1728-34.
Score: 0.128
-
Fasting Blood Ammonia Predicts Risk and Frequency of Hepatic Encephalopathy Episodes in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2016 06; 14(6):903-906.e1.
Score: 0.128
-
Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio. Mol Genet Metab. 2013 Dec; 110(4):446-53.
Score: 0.110
-
End-stage liver disease complications. Curr Opin Gastroenterol. 2013 May; 29(3):257-63.
Score: 0.106
-
Complications of cirrhosis. Curr Opin Gastroenterol. 2012 May; 28(3):223-9.
Score: 0.099
-
Complications and outcomes in chronic liver disease. Curr Opin Gastroenterol. 2011 May; 27(3):204-9.
Score: 0.093